Related Experiment Video
Updated: Feb 1, 2026
10:42
Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
17.9K
[Bleeding Management under Direct Oral Anticoagulants (DOAC)]
Jürgen Koscielny1, Christoph Rosenthal2, Christian von Heymann2
1Gerinnungsambulanz mit Hämophiliezentrum im ambulanten Gesundheitszentrum (AGZ), Charité, Campus Mitte (CCM), Universitätsmedizin Berlin.
Deutsche Medizinische Wochenschrift (1946)
|December 4, 2018
Summary
Managing bleeding with direct oral anticoagulants (DOACs) remains challenging. Mild bleeding requires dose adjustment, while severe cases necessitate hemodynamic stabilization and specific factor concentrates for Factor Xa inhibitor bleeds.
Area of Science:
- Pharmacology
- Hematology
- Internal Medicine
Background:
- Direct oral anticoagulants (DOACs) are widely prescribed, yet managing bleeding complications presents challenges.
- Existing guidelines offer some recommendations, but uncertainty persists regarding optimal patient care during DOAC-associated bleeding events.
Purpose of the Study:
- To clarify management strategies for bleeding complications associated with direct oral anticoagulants (DOACs).
- To differentiate treatment approaches based on bleeding severity and specific DOAC agents.
Main Methods:
- Review of current recommendations and consensus statements on DOAC-associated bleeding.
- Analysis of treatment options including supportive care, laboratory monitoring, and specific reversal agents.
Main Results:
- Mild bleeding typically managed with dose adjustment; laboratory analysis indicated for severe liver/kidney impairment.
- Moderate to severe bleeding requires cardiopulmonary stabilization and source-specific treatment.
- Life-threatening bleeding necessitates hemodynamic stabilization and specialized hemostasis management, including procoagulants (e.g., PCC) for Factor Xa inhibitor bleeds.
Conclusions:
- Treatment algorithms for severe DOAC-associated bleeding are crucial.
- Specific reversal agents like idarucizumab (for dabigatran) are available, while andexanet alfa is not yet approved in the EU for Factor Xa inhibitors.
More Related Videos
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.4K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.4K
01:22Bleeding in Fresh Concrete
578
Bleeding in fresh concrete occurs when water from the mix rises to the surface. This happens because the mix's solid components fail to retain all the water as they settle, leading to separation where water collects at the top. The severity of bleeding can be measured by assessing the total settlement or by noting the decrease in height per unit height of concrete.
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
578
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.9K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.9K
01:11Oral Cavity
3.1K
The oral cavity, or the mouth, is a complex structure in humans that plays a vital role in our day-to-day lives. Its role is not only in chewing and swallowing food; it also plays a role in speech and facial expressions.
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
3.1K
01:09Directing Effect of Substituents: meta-Directing Groups
6.0K
Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.0K
01:06Oral Hypoglycemic Agents: Glinides
663
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
663